Fingolimod versus natalizumab in patients with relapsing...

  • Main
  • 2018 / 12
  • Fingolimod versus natalizumab in patients with relapsing...

Fingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in IRAN

Rezaee, Mehdi, Izadi, Sadegh, Keshavarz, Khosro, Borhanihaghighi, Afshin, Ravangard, Ramin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2018.1560750
Date:
December, 2018
File:
PDF, 1.13 MB
english, 2018
Conversion to is in progress
Conversion to is failed